Publication
Number of items: 30.
22 April 2025
  • Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues. (2025) Fabrizio Schifano, Stefania Bonaccorso, Davide Arillotta, Amira Guirguis, John Martin Corkery, Giuseppe Floresta, Gabriele Duccio Papanti Pelletier, Norbert Scherbaum and Nicolò Schifano
    • 3 April 2025
  • Psychological and Clinical Parameters as Predictors of Relapse in Alcohol-Dependent Patients During and After Extensive Inpatient Rehabilitation Treatment. (2025) Josef Rabl, Dieter Geyer, Katharina Steiner, Fabrizio Schifano and Norbert Scherbaum
    • 10 March 2025
  • The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis. (2025) Tayler Holborn, Fabrizio Schifano, Emma Smith and Paolo Deluca
    • 3 March 2025
  • Effect of Different Frequencies of Transcutaneous Electrical Acupoint Stimulation (TEAS) on EEG Source Localization in Healthy Volunteers : A Semi-Randomized, Placebo-Controlled, Crossover Study. (2025) Rael Lopes Alves, Maxciel Zortea, David Mayor, Tim Watson and Tony Steffert
    • 10 February 2025
  • From Veterinary Medicine to Illicit Drug Supply: Utilising Social Media to Explore the Rising Emergence of Veterinary Medicines in Human Health. (2025) Josie Dunn, Fabrizio Schifano, Ed Dudley, Davide Arillotta and Amira Guirguis
    • 19 December 2024
  • Obsessive–Compulsive Symptoms in the General Population Under Stressful Conditions: Lessons Learned from the COVID-19 Pandemic. (2024) Luca Pellegrini, Umberto Albert, Claudia Carmassi, Giuseppe Carrà, Francesca Cirulli, Bernardo Dell’Osso, Matteo Di Vincenzo, Mario Luciano, Maria Giulia Nanni, Maurizio Pompili, Gabriele Sani, Alfonso Tortorella, Umberto Volpe, Andrea Fiorillo and Gaia Sampogna
    • 20 November 2024
  • Neuropsychological Abnormalities Associated with Alcohol Dependence During Long-Term Rehabilitation Treatment of German Inpatients. (2024) Josef Rabl, Dieter Geyer, Dario Kroll, Fabrizio Schifano and Norbert Scherbaum
    • 7 November 2024
  • Neuroplastic Responses to Chiropractic Care: Broad Impacts on Pain, Mood, Sleep, and Quality of Life. (2024) Heidi Haavik, Imran Khan Niazi, Imran Amjad, Nitika Kumari, Usman Ghani, Moeez Ashfaque, Usman Rashid, Muhammad Samran Navid, Ernest Nlandu Kamavuako, Amit N Pujari and Kelly Holt
    • 20 June 2024
  • Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. (2024) Davide Arillotta, Giuseppe Floresta, G. Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano
    • 20 April 2024
  • Imagery and Verbal Strategies in Spatial Memory for Route and Survey Descriptions. (2024) Ioanna Markostamou, Sol Morrissey and Michael Hornberger
    • 31 December 2023
  • The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database. (2023) Sara Baldini, Ahmed Khattak, Paolo Capogrosso, Gabriele Antonini, Federico Dehò, Fabrizio Schifano and Nicolò Schifano
    • 24 October 2023
  • GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. (2023) Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
    • 19 November 2022
  • Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels’ Decline: A Narrative Review. (2022) Nicolò Schifano, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Paolo Capogrosso, Federico Dehò, Giovanni Martinotti and Fabrizio Schifano
    • 21 July 2022
  • Gender Differences in the Psychopathology of Obesity: How Relevant Is the Role of Binge Eating Behaviors? (2022) Chiara Di Natale, Lorenza Lucidi, Chiara Montemitro, Mauro Pettorruso, Rebecca Collevecchio, Lucia Di Caprio, Luana Giampietro, Liberato Aceto, Giovanni Martinotti and Massimo di Giannantonio
    • 9 July 2021
  • Covid-19 pandemic impact on substance misuse: a social media listening, mixed method analysis. (2021) Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum and Fabrizio Schifano
    • 27 June 2021
  • Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. (2021) Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo D’Andrea, Roberta Collevecchio, Ilenia Di Muzio, Stefano L. Sensi and Massimo Di Giannantonio
    • 10 March 2021
  • The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review. (2021) Safia Sharif, Amira Guirguis, Suzanne Fergus and Fabrizio Schifano
    • 14 October 2020
  • What about “Pharming”? Issues Regarding the Misuse of Prescription and Over‐the‐Counter Drugs. (2020) Stefania Chiappini and Fabrizio Schifano
    • 16 March 2020
  • The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS. (2020) Fabrizio Schifano
    • 4 March 2020
  • Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects. (2020) Fabrizio Schifano
    • 2 March 2020
  • Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances. (2020) Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anne-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Corkery and Fabrizio Schifano
    • 16 February 2020
  • Focus on clozapine withdrawal- and misuse-related cases, as reported to the European Medicines Agency (EMA) pharmacovigilance database. (2020) Stephania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis
    • 20 July 2019
  • Common and Distinct Functional Brain Networks for Intuitive and Deliberate Decision Making. (2019) Burak Erdeniz and D. John Done
    • 17 January 2019
  • Recent Changes in Drug Abuse Scenario: The New/Novel Psychoactive Substances (NPS) Phenomenon. (2019)
    • 13 December 2018
  • Recent changes in drug abuse scenarios : The new/novel psychoactive substances (NPS) phenomenon. (2018) Fabrizio Schifano
    • 14 July 2018
  • Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings : Clinical presentation and management issues. (2018) Stefania Bonaccorso, Antonio Metastasio, Angelo Ricciardi, Neil Stewart, Leila Jamal, Naasir Ud Dinn Rujully, Christos Theleritis, Stefano Ferracuti, Giuseppe Ducci and Fabrizio Schifano
    • 14 May 2018
  • Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services. (2018) Antonio Metastasio, Attilio Negri, Giovanni Martinotti and Ornella Corazza
    • 22 April 2018
  • Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. (2018) Fabrizio Schifano, Stefania Chiappini, John Corkery and Amira Guirguis
    • 30 March 2018
  • Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. (2018) Rosalind Gittins, Amira Guirguis, Fabrizio Schifano and Ian Maidment
    • 20 February 2018
  • Octodrine: New Questions and Challenges in Sport Supplements. (2018) Valeria Catalani, Mariya Prilutskaya, Ahmed Al-Imam, Shanna Marrinan, Yasmine Elgharably, Mire Zloh, Giovanni Martinotti, Robert Chilcott and Ornella Corazza